ABSTRACT Background An accurate estimation of progression risk in patients with prostate cancer (PCa) amenable to active surveillance (AS) is still an unmet need. Among available biomarkers, we considered Prolaris cell‐cycle progression (CCP) test, “triple hit” phenotype (ERG overexpression, PTEN and prostein expression loss) and elevated expression ...
Marco Oderda+14 more
wiley +1 more source
Urological dysfunctions in patients with Parkinson’s disease: clues from clinical and non-invasive urological assessment [PDF]
Francesca Valentino+9 more
openalex +1 more source
Dual-Energy CT Applications in Urological Diseases [PDF]
Michaela Cellina+9 more
openalex +1 more source
Hyperuricemia and Urologic Disease
In-Chang Cho, Seung Ki Min
openaire +2 more sources
Late Bowel Symptoms in Long‐Term Survivors of Prostate Cancer Following Radiotherapy
ABSTRACT Background Despite advances in radiotherapy planning, some long‐term prostate cancer survivors experience persistent symptoms. Although overall quality of life appears comparable between patients treated with definitive and salvage radiotherapy and aligns with normative data, prostate‐specific deficits—particularly bowel symptoms—may persist ...
Isabella Gruber+2 more
wiley +1 more source
Prominence of Sexually Transmitted Diseases in a Downtown Urological Clinic
Masayuki Sawamura
openalex +2 more sources
Understanding urologic scientific publication patterns and general public interests on stone disease: lessons learned from big data platforms [PDF]
Giovanni Scala Marchini+9 more
openalex +1 more source
Recent Advances in Cell Membrane Coated-Nanoparticles as Drug Delivery Systems for Tackling Urological Diseases [PDF]
Cenchao Yao+3 more
openalex +1 more source
THE APPLICATION OF STATISTICAL METHODS IN EVALUATING THE RESULTS OF CLINICAL FINDINGS OF THE DRUG BOVHUALONIDASE AZOXIMER IN CATS WITH UROLOGICAL DISEASES [PDF]
А.В. Назарова+2 more
openalex +1 more source